Drugs / vGCV
last change Sep 2013 re-read 2 minutes ago

vGCV

Developed for
prostate cancer
Investigated by
Henry Ford Health System

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00583492 Dec 2007 → Sep 2013 prostate cancer Henry Ford Health System Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as vGCV “Plus 2 week course (weekdays only) of 5-FC and vGCV prodrug therapy” NCT00583492